These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11082513)

  • 1. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
    Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
    Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
    Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
    Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
    Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
    Jiménez P; Cantón J; Collado A; Cabrera T; Serrano A; Real LM; García A; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1999 Sep; 83(1):91-7. PubMed ID: 10449614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
    Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
    Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
    Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria to define HLA haplotype loss in human solid tumors.
    Ramal LM; Feenstra M; van der Zwan AW; Collado A; Lopez-Nevot MA; Tilanus M; Garrido F
    Tissue Antigens; 2000 May; 55(5):443-8. PubMed ID: 10885565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
    Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
    Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
    Maleno I; Lopez Nevot MA; Seliger B; Garrido F
    Int J Cancer; 2004 Apr; 109(4):636-8. PubMed ID: 14991587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
    Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
    Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
    Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
    Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.
    Linjama T; Impola U; Niittyvuopio R; Kuittinen O; Kaare A; Rimpiläinen J; Volin L; Peräsaari J; Jaatinen T; Lauronen J; Saarinen T; Juvonen E; Partanen J; Koskela S
    HLA; 2016 May; 87(5):350-5. PubMed ID: 26969202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
    Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
    Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.